...$105 million series B raise that tripled its reserves.Australia’s Clarity Pharmaceuticals Pty. Ltd. and Germany’s PentixaPharm GmbH...
...markets. Karen Tkach Tuzman Point Biopharma Inc. Aktis Oncology Fusion Pharmaceuticals Inc. RayzeBio Inc. Actinium Pharmaceuticals Inc. Nordic Nanovector ASA Clarity Pharmaceuticals Pty. Ltd. PentixaPharm GmbH radiotherapy radiotherapies radiopharmaceuticals targeted...

...With its €15 million ($16.5 million) series A led by ELSA Eckert Life Science Accelerator, PentixaPharm GmbH...
...4 TREM1 - Triggering receptor expressed on myeloid cells 1 BioCentury Staff Adverum Biotechnologies Inc. Theravance Biopharma Inc. Inotrem S.A. PentixaPharm GmbH...